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Introduction: Extracorporeal membrane oxygenation (ECMO) is being increasingly used to 
provide support in patients with refractory cardiopulmonary distress syndromes. Neurological 
sequelae, either from the ECMO or the hypoxic/hypotensive event leading to ECMO, are 
common. We present a patient requiring veno-venous (V-V) ECMO for an acute respiratory 
distress syndrome (ARDS) following cardiopulmonary arrest who suffered an irreversible brain 
injury. Eventually she required an evaluation for death by neurological criteria while on V-V 
ECMO making apnea testing challenging. We report the ability to safely perform apnea testing 
in a patient with a devastating brain injury requiring V-V ECMO.  
Case: A 33-year-old female initially presented with flu-like symptoms. Following admission, she 
suffered a cardiac arrest with return of spontaneous circulation, but developed severe ARDS 
requiring V-V ECMO. Computed tomography (CT) of the head showed effacement of basal 
cisterns and cortical sulci consistent with a global cerebral edema. Continuous 
electroencephalography (cEEG) showed background suppression. After addressing confounding 
factors, her physical exam confirmed complete absence of brainstem reflexes. Apnea testing was 
performed by adjusting the sweep rate to provide a hemodynamically stable increase in PaCO2. 
Conclusion: Apnea testing in patients on V-V ECMO can be safely performed by adjusting the 
sweep rate. The adjustment should be individualized for the patient.   
 
Keywords: Extracorporeal membrane oxygenation (ECMO), brain death, apnea test, continuous 
electroencephalography (CEEG) 
 
 
INTRODUCTION 
 
Extracorporeal membrane oxygenation 
(ECMO) is being increasingly used to 
provide support in patients with refractory 
cardiopulmonary distress.1 It can be 
delivered by two methods: veno-venous (V-
V) or veno-arterial (V-A). The 
determination of the method to be used 
depends on the patient’s cardiac function.2 
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V-V ECMO provides a lung bypass for 
hypoxia relief, and V-A ECMO provides a 
cardiopulmonary bypass for a refractory 
cardiogenic shock2.   
Neurological sequelae, either from 
the ECMO or the hypoxic or hypotensive 
event necessitating ECMO, have been 
shown to occur in up to 50% of patients.3 Up 
to 28% of non-survivors on ECMO may 
suffer severe brain injury that may progress 
to brain death.4 While physical exam can be 
performed in such patients, performing an 
apnea test may be challenging. A requisite 
for supporting the diagnosis of brain death is 
the apnea test, which is considered positive 
if there are no respiratory movements as 
blood carbon dioxide (PaCO2) is allowed to 
increase by 20 mmHg over a baseline 
PaCO2 or reach levels greater than 60 
mmHg.5,6 We report here the feasibility of 
performing an apnea test in a patient with a 
devastating brain injury requiring V-V 
ECMO.  
 
CASE REPORT 
 
A 33-year-old female with a past medical 
history of diabetes mellitus type 2, 
hypertension, and alcohol abuse presented to 
the emergency department (ED) with flu-
like symptoms. While in the ED, she 
became unresponsive and pulseless. 
Cardiopulmonary resuscitation (CPR) was 
initiated for pulseless electrical activity 
(PEA) reverting to ventricular fibrillation 
(VFib) after receiving epinephrine 1 mg. 
She received one shock along with 
bicarbonate, dextrose, calcium, and 
amiodarone with return of spontaneous 
circulation (ROSC) after 6 minutes. She 
remained in a coma, and targeted 
hypothermia for a goal of 32-34oC was 
started. She developed hypotension, and in 
order to keep mean arterial pressure (MAP) 
> 65mmHg she required norepinephrine, 
dopamine, phenylephrine, and vasopressin. 
She was started on broad-spectrum 
antibiotics including: vancomycin, 
cefepime, and metronidazole.  
Ongoing refractory hypotension and 
hypoxia (oxygen saturations in mid to low 
80%) continued requiring manual bag mask 
valve ventilation and an epinephrine 
infusion. Further course was complicated by 
symptomatic bradycardia requiring atropine, 
which progressed to PEA and again required 
CPR. She received epinephrine 1 mg with 
resulting rhythm showing VFib. She then 
received one shock before ROSC. Her 
infectious disease coverage was broadened 
to vancomycin, cefepime, metronidazole, 
ampicillin, oseltamivir, and tobramycin.  
She continued to have refractory 
hypoxia despite adjustments to the 
mechanical ventilation, anticoagulation for 
suspected pulmonary embolus, and inhaled 
nitric oxide. Her oxygen saturation 
improved to 90% with a recurrent decline 
requiring prone ventilation for an acute 
respiratory distress syndrome (ARDS). With 
no improvement, V-V ECMO was initiated 
emergently with cannulation via the right 
internal jugular vein. She remained on the 
ventilator with a FiO2 of 50%, tidal volume 
(Tv) of 200 cc, positive end expiratory 
pressure (PEEP) of 5 cmH20, and a 
respiratory rate (RR) of 20/min. She was 
rewarmed after 24 hours of cooling.  
She remained comatose and was 
noted to have bilateral, nonreactive pupils of 
4 mm and a generalized myoclonus. She was 
started on levetiracetam. A computed 
tomography (CT) of the head did not show 
any acute intracranial process. Continuous 
electroencephalography (cEEG) showed 
burst suppression pattern (Figure 1A). Over 
the next 48 hours, her myoclonus resolved. 
cEEG showed evolution from burst 
suppression to generalized periodic 
discharges to background suppression (<2 
uV) without bursts (Figure 1A-D). Her 
neurological examination worsened to 
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Figure 1. Evolution of continuous electroencephalography (cEEG) in a Patient on ECMO. (A) Burst suppression 
pattern. (B) Generalized periodic pattern. (C) Background suppression (<10uV) with low amplitude muscle artifact. 
(D) Background suppression (<10uV). These changes occurred over 48 hours. Bipolar montage. LFF=1Hz, 
HFF=70Hz, Notch 60Hz, sensitivity 10uV/mm. 
absent brainstem reflexes. Repeat CT of the 
head showed diffuse cerebral edema with 
effacement of the basal cisterns and cortical 
sulci (Figure 2A-D). Given her neurological 
examination and findings on head CT, 
evaluation for death by neurological criteria 
was initiated after ensuring normothermia 
and excluding confounders such as 
sedatives, paralytics and/or metabolic 
derangements. Her systolic blood pressure 
was >100 mmHg. Her neurological 
examination showed coma. There was no 
grimace or changes in vitals to peripheral or 
central noxious stimulation. There was no 
eye opening upon painful stimulation. Pupils 
were 4 mm and nonreactive bilaterally. She 
did not have a corneal reflex or reflexive eye 
movement to head turning or to cold caloric 
stimulation. There was no gag reflex to 
tonsillar stimulation or cough reflex to deep 
endotracheal stimulation. Her motor 
examination showed flaccid quadriparesis 
with no movement to noxious stimulation. 
She was areflexic.  
Her ECMO settings were notable for 
a sweep speed of 3210 rpm, a flow of 3.17 
LPM, an air/oxygen mixer of 80%, and a 
sweep rate of 2L O2/min with SVO2 of 
71%.  In preparation for apnea testing, 
ventilator settings were kept the same (Tv = 
200 cc, PEEP = 5 cmH2O, RR = 20/min), 
but the FiO2 was increased to 100%. She 
had a temperature of 37.1oC. To keep 
systolic blood pressure >100 mmHg she 
remained on pressor support including 
phenylephrine, epinephrine, and 
vasopressin. An arterial blood gas (ABG) at 
the start of testing showed a baseline PaCO2 
of 41 mmHg and a PaO2 of 186 mmHg. The 
sweep rate on the ECMO was changed to 0L 
O2/min. She was disconnected from the 
ventilator. A catheter was advanced through 
the endotracheal tube to the level of the 
carina and delivered 4L/min of 100% 
oxygen. She was monitored with arterial line 
and pulse oximetry. After 5 minutes of 
monitoring, her oxygen saturation quickly 
dropped to 62% saturation. She was placed 
back on the ventilator and the ECMO sweep 
was dialed to 2L O2/min. She was 
preoxygenated again for ~20 minutes. A 
repeat baseline ABG was obtained showing 
a pH of 7.4, a PaCO2 of 43 mmHg, and a 
PaO2 of 212 mmHg. She was again 
disconnected from the ventilator. The 
ECMO sweep was decreased to 900 mL 
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Figure 2. Computed tomography (CT) of the Head Showing Diffuse Cerebral Edema. Complete effacement of sulci 
(A; arrows) and basal cisterns with uncal herniation (D; arrow) and “pseudo-subarachnoid” hemorrhage (D; asterisk) 
are seen.  
 
O2/min. She was again monitored with an 
arterial line and pulse oximetry. Serial 
ABGs were obtained every five minutes. 
The PaCO2 increased to 62 mmHg by 37 
minutes of apnea testing. Her PaO2 was 220 
mmHg and the pH was 7.26. Her oxygen 
saturation throughout the testing remained at 
a 100%. Her systolic blood pressure 
remained >100 mmHg without the need to 
adjust vasopressors. She showed no 
respiratory movement during the 
examination. The apnea test was determined 
to be positive, and she was pronounced dead 
by the neurologic criteria. 
 
DISCUSSION 
 
We present a case of a devastating 
neurological injury progressing to brain 
death in a patient on V-V ECMO. This case 
highlights an approach to safely perform 
apnea testing in a patient on V-V ECMO.  
Brain death is the irreversible 
cessation of function of the whole brain, 
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including the brainstem, with sustained 
systemic perfusion.5 The rest of the organs 
may be supported by mechanical ventilation, 
medications, and other devices, such as 
ECMO, making it challenging to perform 
clinical testing in some circumstances. As a 
pre-requisite to diagnosing brain death, an 
irreversible and proximate cause of coma 
must be present.5 Thus, neuroimaging to 
support a catastrophic brain injury leading to 
brain death is necessary, and the final 
pathway for brain death is cerebral 
circulatory arrest from intracranial 
hypertension.  
An apnea test is a key component for 
brainstem areflexia assessment and requires 
a methodical approach5. Factors such as 
hypothermia that deters PaCO2 production 
and prevents the requisite rise in PaCO2 
must be corrected prior to apnea testing.5 
During the testing, accumulation of PaCO2 
results in an acidosis causing a predictable 
drop in blood pressure.5 Thus, pressor 
support may be necessary.  
While monitoring for any 
spontaneous respiratory effort during the 
apnea testing, it is recommended to detach 
the patient from the ventilator and provide 
oxygen via the endotracheal tube at 4-6 
L/min using a suction catheter attached to 
the wall oxygen. If higher oxygen flow rate 
is used, it may wash out the PaCO2 and 
ultimately prevent accumulation in the 
blood.7 It is recommended to continue 
testing for a minimum of 10 minutes since 
the slowest rise in PaCO2 in euthermia is 2 
mmHg/min.7 However, in patients on 
ECMO, these guidelines may need to be 
modified.  
 ECMO is a method to directly 
oxygenate the blood and remove carbon 
dioxide from the blood.2 There are two types 
of ECMO: V-V and V-A ECMO. 2 The 
choice of ECMO is based on organ failure.2 
If the primary problem is lung failure, for 
example an acute respiratory distress 
syndrome like in our case, V-V ECMO is 
used as the salvage therapy.2 In V-V ECMO, 
blood is withdrawn from the vein into the 
extracorporeal membrane by a mechanical 
pump. It then enters the oxygenator. A 
blood-gas interface is present across a 
membrane allowing for diffusion of gas. 
This blood gas interface is created from 
fresh gas known as the sweep gas. The 
composition of the gas is adjusted by a 
blender allowing for the determination of the 
fraction of delivered oxygen. The removal 
of carbon dioxide is controlled by adjusting 
the flow rate of the sweep gas. By 
decreasing the sweep flow rate, less carbon 
dioxide is removed. The oxygenated 
extracorporeal blood is then returned to the 
central venous system.8  
 The appropriate ventilator strategy 
with a patient on ECMO is individualized 
while employing lung protective ventilator 
strategy. This approach may include using 
low tidal volumes (less than 4 cc/kg of 
predicted body weight), higher PEEP (10-15 
cmH20), peak inspiratory pressure of 20-25 
cmH20, respiratory rate of 10 bpm, and a 
FiO2 of 30%. Oxygenation is provided by 
ECMO.2 
 Unfortunately, several neurological 
complications have been observed in 
patients on ECMO.9 These events may be 
from the insult that led to the ECMO or a 
result of the ECMO procedure itself and 
may occur up to 50% of patients on 
ECMO.3,9,10 A retrospective study of the 
Extracorporeal Life Support Organization 
registry found neurological complications to 
be common and include: cerebral infarction 
(3.6%), seizure (1.8%), intracerebral 
hemorrhage (1.8%), and brain death 
(7.9%).9 Presence of central nervous system 
(CNS) complications predicted higher 
mortality (89%) compared to 57% in 
patients without CNS complications.9 This 
highlights the importance of monitoring and 
controlling for these devastating events.  
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 If a patient is suspected to have 
progressed to brain death, apnea testing can 
be challenging while on ECMO, but can be 
performed safely.11 Different approaches 
have been recommended in literature 
including avoiding apnea testing 
altogether.11-14 We report that apnea testing 
can be performed safely with sweep flow 
rate kept above zero to maintain 
normoxemia. This finding is in contrast to 
the case report by Shah et al. (2015).14 
Additionally, we show that there was no 
need for oxygenation through the 
endotracheal tube. Patients on ECMO are 
not relying on the alveolar gradient allowing 
for the diffusion of oxygen to maintain 
normoxemia. The purpose of mechanical 
ventilation while on ECMO is to prevent 
further lung injury, not to provide 
oxygenation. We arbitrarily chose a sweep 
rate of 900 cc/min. It took approximately 37 
minutes before PaCO2 rose above 60 
mmHg. Lower sweep rates may be 
considered to allow for a quicker rise in 
PaCO2, but may lead to hemodynamic 
instability. It is recommended to use the 
lowest sweep rate possible to prevent 
desaturation and to maintain hemodynamic 
stability.  
 In conclusion, we demonstrate the 
feasibility and safety of performing the 
apnea test in a patient with devastating brain 
injury on V-V ECMO.  
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